FDA Inspection 1051233 — Tata Memorial Centre
The FDA completed an inspection of Tata Memorial Centre on Mar 23, 2018 in Navi Mumbai. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 23, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Navi Mumbai (India)
Additional Details
Clinical BA/BE